ZEVRA THERAPEUTICS INC (ZVRA) Stock Analyst Ratings
USA - NASDAQ:ZVRA - US4884452065 - Common Stock
9.4 USD
-0.03 (-0.32%)
9.45 USD
+0.05 (+0.53%)
ChartMill assigns a Buy % Consensus number of 84% to ZVRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 160.43% above the current price.
ZVRA was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ZVRA.
In the previous month the buy percentage consensus was at a similar level.
ZVRA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-10 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-07-02 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-13 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-10-07 | Guggenheim | Initiate | Buy |
| 2024-10-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-24 | Roth MKM | Maintains | Buy -> Buy |
| 2024-09-24 | JMP Securities | Initiate | Market Outperform |
| 2024-09-24 | Maxim Group | Maintains | Buy -> Buy |
| 2024-09-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-05 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-03-12 | William Blair | Initiate | Outperform |
| 2024-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
ZEVRA THERAPEUTICS INC / ZVRA FAQ
Can you provide the average price target for ZEVRA THERAPEUTICS INC stock?
14 analysts have analysed ZVRA and the average price target is 24.48 USD. This implies a price increase of 160.43% is expected in the next year compared to the current price of 9.4.
What is the consensus rating for ZEVRA THERAPEUTICS INC (ZVRA) stock?
The consensus rating for ZEVRA THERAPEUTICS INC (ZVRA) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.